United States · Series B startup

Who invested in Aspyrian Therapeutics

3 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$28Mraised across 3 rounds since 2015, from 3 sources

$8.4MVenture$4.3MSeries A$15MSeries B
Latest round
Series B, $15MJul 2017
Step-upi
3.6×
Investors
1
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201520162017
$8.4MVenture$4.3MSeries A$15MSeries B
First round
Venture, $8.4M
Jan 2015
Biggest round
$15M
Series B · Jul 2017
Usual gap between rounds
2 years
the median of 2

The rounds

  1. Jul 2017
    Series B$15M1 new

    Reported by FinSMEsSEC filing: $15M sold, first sale Jul 2017

  2. Jul 2015
    Series A$4.3M

    No investor was named in the report.

    From a historical funding recordSEC filing: $4.2M sold, first sale Jul 2015

  3. Jan 2015
    Venture$8.4M

    No investor was named in the report.

    From a historical funding recordSEC filing: $8.5M sold, first sale Dec 2014

Founders and team

From the SEC filings it signed: 2 on the team.

  • Merrill BielExecutive Officer, Directori
  • Miguel Garcia-GuzmanExecutive Officer, Directori

On the board, as filediHiroshi MikitaniHiroshi Mori

Everyone who backed them

Hiroshi MikitaniGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Aspyrian Therapeutics

Who invested in Aspyrian Therapeutics?

Aspyrian Therapeutics's investors include Hiroshi Mikitani.

How much has Aspyrian Therapeutics raised?

Aspyrian Therapeutics has raised $28M across 3 rounds since 2015.

When did Aspyrian Therapeutics last raise?

Aspyrian Therapeutics's most recent round was a Series B of $15M in Jul 2017.

What was Aspyrian Therapeutics's biggest round?

Its most recent round, $15M in Jul 2017, is also its largest on record.

Who backed Aspyrian Therapeutics first?

Aspyrian Therapeutics's first round on record, in Jul 2017, was backed by Hiroshi Mikitani.

What stage is Aspyrian Therapeutics at?

Aspyrian Therapeutics's latest named round is a Series B, in Jul 2017.

Where is Aspyrian Therapeutics based?

Aspyrian Therapeutics is based in the United States.

Companies like Aspyrian Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.